Skip to content
MedsAcross

Medicine

Pokonza 0.75 g/0.79 g powder for oral solution

Potassium chloride · Oral · Carwin Pharmaceutical Associates
Available on requestPrescription onlyUS FDA

Pokonza 0.75 g/0.79 g powder for oral solution is a prescription medicine containing Potassium chloride for oral use, marketed by Carwin Pharmaceutical Associates, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at Controlled Room Temperature, 25°C (77°F), excursions are permitted to…

Key facts

Active ingredient (INN)
Potassium chloride
Brand
Pokonza
Strength
0.75 g/0.79 g
Dosage form
Powder for oral solution
Route
Oral
Packs
4 pouches, 30 pouches, 60 pouches and 2 more
Marketing authorisation holder
Carwin Pharmaceutical Associates
Manufacturer
Carwin Pharmaceutical Associates
Origin register
US FDA, United States
Storage
Store at Controlled Room Temperature, 25°C (77°F), excursions are permitted to 15°C to 30°C (59°F to 86°F). Dispense in a tight, light-resistant container as defined in the USP Protect from Light.
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
A12BA01 Potassium chloride
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
19 September 2023
Identifiers
RxCUI 2665269, 2665275, 2729280 +1DailyMed set ID 7c5cc705-e5da-4487-86c9-9d545a95afb4, 0700c19e-abca-4527-8944-e4440a32e3afNDC 15370-305, 15370-306Application NDA208019

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

PackCodeLabelerMarketed since
4 pouch in 1 carton / .79 g in 1 pouch15370-305-04Carwin Pharmaceutical Associates19 September 2023
30 pouch in 1 carton / .79 g in 1 pouch15370-305-30Carwin Pharmaceutical Associates18 March 2024
60 pouch in 1 carton / .79 g in 1 pouch15370-305-60Carwin Pharmaceutical Associates19 September 2023
30 pouch in 1 carton / 1.185 g in 1 pouch15370-306-30Carwin Pharmaceutical Associates9 December 2025
60 pouch in 1 carton / 1.85 g in 1 pouch15370-306-60Carwin Pharmaceutical Associates9 December 2025

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 25 April 1975Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Other strengths and forms of Potassium chloride

Clinical summary

Potassium chloride is an osmotic laxative indicated for the treatment and prophylaxis of hypokalemia with or without metabolic alkalosis, in patients for whom dietary management with potassium-rich foods or diuretic dose reduction is insufficient. MedsAcross supplies Potassium chloride for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Potassium chloride

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Pokonza 0.75 g/0.79 g powder for oral solution for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.